Valoctocogene roxaparvovec Uses, Dosage, Side Effects and more
Valoctocogene roxaparvovec is under investigation in clinical trial NCT03392974 (Single-arm Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia a Patients at a Dose of 4E13 Vg/kg).
| Attribute | Details |
|---|---|
| Trade Name | Valoctocogene roxaparvovec |
| Generic | Valoctocogene roxaparvovec |
| Valoctocogene roxaparvovec Other Names | Valoctocogene roxaparvovec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
